Stock listing
Diamedica Therapeutics Inc.
Selected listing: DMAC · NASDAQ · USD · US
Diamedica Therapeutics Inc. (NASDAQ:DMAC), Health Technology. Latest release Sep 30, 2026: DiaMedica Therapeutics Announces Key Opinion Leader Webinar…
- Ticker
- NASDAQ:DMAC
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
About Diamedica Therapeutics Inc.
The company focuses on developing innovative therapies for neurological diseases. Its commitment to advancing healthcare solutions positions it as a notable player in the biotechnology sector.
Latest news from Diamedica Therapeutics Inc.
DiaMedica Therapeutics Announces Key Opinion Leader Webinar on DM199 for Fetal Growth Restriction Featuring Early Phase 2 FGR Results
September 30, 2026
DiaMedica Therapeutics Announces Key Opinion Leader Webinar on DM199 for Fetal Growth Restriction Featuring Early Phase 2 FGR Results
September 29, 2026
DiaMedica Therapeutics to Participate in Upcoming September Investor Conferences
September 2, 2026
DiaMedica Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Highlights
August 10, 2026
DiaMedica Therapeutics to Report Second Quarter 2026 Financial Results and Provide a Business Update August 11, 2026
August 4, 2026
Events
Research Diamedica Therapeutics Inc.
Diamedica Therapeutics Inc. company profile
View the public company page for Diamedica Therapeutics Inc. on 6ix.
Diamedica Therapeutics Inc. news
Read company news and market updates connected to Diamedica Therapeutics Inc..
Diamedica Therapeutics Inc. investor events
Find investor webinars, events, and replay context for Diamedica Therapeutics Inc..